Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Decision making and decision support for hereditary breast-ovarian cancer susceptibility.

Health psychology : official journal of the Division of Health Psychology, American Psychological Association - 1 Jul 2005

Schwartz Marc D, Peshkin Beth N, Tercyak Kenneth P, Taylor Kathryn L, Valdimarsdottir Heiddis

Abstract excerpt

Genetic testing for disease susceptibility has the potential to revolutionize health care by allowing for individually tailored disease prevention strategies. To achieve this promise, patients and physicians must use the information obtained through genetic testing to make medical decisions that are consistent with patient preferences and that lead to reduced disease morbidity and mortality. However, decisions...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Decision Making

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Ovarian Neoplasms

Share to Patient Acceptance of Health Care

Share to Patient Participation

Share to United States

Source

Identifiers

PMID: 16045423
DOI: 10.1037/0278-6133.24.4.S78

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Decision making and decision support for hereditary breast-ovarian cancer susceptibility.PMID 16045423Read ↗

Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors.Semantic proximity Read ↗

Psychosocial issues associated with genetic testing for breast and ovarian cancer risk: an integrative review.Semantic proximity Read ↗

Understanding risk perception and risk-reducing decision-making for surgery among individuals with a genetic predisposition to epithelial ovarian cancer.Semantic proximity Read ↗

Comprehensive Care of Women With Genetic Predisposition to Breast and Ovarian Cancer.Semantic proximity Read ↗

BRCA1 and BRCA2 gene mutations: decision-making dilemmas concerning testing and management.Semantic proximity Read ↗

How Should Decision Aids Be Used During Counseling to Help Patients Who Are "Genetically at Risk"?Semantic proximity Read ↗

Genetic testing and cancer risk management recommendations by physicians for at-risk relatives.Semantic proximity Read ↗

Reproductive decision-making in cancer susceptibility syndromes.Semantic proximity Read ↗

Factors that differentiate cancer risk management decisions among females with pathogenic/likely pathogenic variants in PALB2, CHEK2, and ATM.Semantic proximity Read ↗

Complex decision-making for BRCA1/2 carriers.Semantic proximity Read ↗

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force.Semantic proximity Read ↗

Patients' attitudes about autonomy and confidentiality in genetic testing for breast-ovarian cancer susceptibilitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.